Sustainability
Accelerating global access
Our company is collaborating with a range of partners to enable access for patients around the world
September 8, 2022
At the outset of our research efforts for COVID-19, our company made clear its commitment to make any vaccine or medicine we develop for this pandemic broadly accessible.
Here’s how we have been working to fulfill that commitment:
